These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33611321)

  • 41. Retinopathy of prematurity in extremely premature infants: multiple births versus single births.
    Petriçli İS; Kara C; Demirel N; Ulubaş Işık D; Baş AY
    Turk J Med Sci; 2018 Feb; 48(1):131-135. PubMed ID: 29479971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity.
    Machalinska A; Modrzejewska M; Kotowski M; Dziedziejko V; Kucia M; Kawa M; Safranow K; Baskiewicz-Masiuk M; Modrzejewska A; Karczewicz D; Rudnicki J; Machalinski B
    Arch Ophthalmol; 2010 Oct; 128(10):1311-9. PubMed ID: 20938001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and risk factors for retinopathy of prematurity in premature, extremely low birth weight and extremely low gestational age infants.
    Yucel OE; Eraydin B; Niyaz L; Terzi O
    BMC Ophthalmol; 2022 Sep; 22(1):367. PubMed ID: 36096834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fetal oxidative stress, micronutrient deficiency and risk of retinopathy of prematurity: a nested case-control study.
    Agrawal G; Dutta S; Prasad R; Dogra MR
    Eur J Pediatr; 2021 May; 180(5):1487-1496. PubMed ID: 33410943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
    Wu WC; Lien R; Liao PJ; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
    JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain-derived neurotrophic factor in infants <32 weeks gestational age: correlation with antenatal factors and postnatal outcomes.
    Rao R; Mashburn CB; Mao J; Wadhwa N; Smith GM; Desai NS
    Pediatr Res; 2009 May; 65(5):548-52. PubMed ID: 19190539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants.
    Cakir B; Hellström W; Tomita Y; Fu Z; Liegl R; Winberg A; Hansen-Pupp I; Ley D; Hellström A; Löfqvist C; Smith LE
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 33004691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.
    Vinekar A; Nair AP; Sinha S; Vaidya T; Chakrabarty K; Shetty R; Ghosh A; Sethu S
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):2. PubMed ID: 33646290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.
    ; Hartnett ME; Wallace DK; Dean TW; Li Z; Boente CS; Dosunmu EO; Freedman SF; Golden RP; Kong L; Prakalapakorn SG; Repka MX; Smith LE; Wang H; Kraker RT; Cotter SA; Holmes JM
    JAMA Ophthalmol; 2022 Apr; 140(4):337-344. PubMed ID: 35446359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lower foetal haemoglobin levels at 31- and 34-weeks post menstrual age is associated with the development of retinopathy of prematurity : PacIFiHER Report No. 1 PacIFiHER Study Group (Preterm Infants and Fetal Haemoglobin in ROP).
    Jiramongkolchai K; Repka MX; Tian J; Aucott SW; Shepard J; Collins M; Kraus C; Clemens J; Feller M; Burd I; Roizenblatt M; Goldberg MF; Arevalo JF; Gehlbach P; Handa JT
    Eye (Lond); 2021 Feb; 35(2):659-664. PubMed ID: 32409707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship of retinopathy of prematurity with brain-derivated neurotrophic factor, vascular endotelial growth factor-A, endothelial PAD domain protein 1 and nitric oxide synthase 3 gene polymorphisms.
    Ilguy S; Cilingir O; Bilgec MD; Ozalp O; Erzurumluoglu Gokalp E; Arslan S; Tekin N; Aydemir O; Erol N; Colak E; Gursoy H
    Ophthalmic Genet; 2021 Dec; 42(6):725-731. PubMed ID: 34346275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for severe retinopathy of prematurity in premature infants: a single-center study.
    Ke XY; Ju RH; Zhang JQ; Chen H; Wei EX; Chen XH
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1963-7. PubMed ID: 22200692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity.
    Wade KC; Ying GS; Baumritter A; Gong A; Kemper AR; Quinn GE;
    JAMA Ophthalmol; 2019 Feb; 137(2):160-166. PubMed ID: 30452500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity.
    Shulman JP; Weng C; Wilkes J; Greene T; Hartnett ME
    JAMA Ophthalmol; 2017 Sep; 135(9):947-953. PubMed ID: 28796851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retinopathy of prematurity and risk factors: a prospective cohort study.
    Karna P; Muttineni J; Angell L; Karmaus W
    BMC Pediatr; 2005 Jun; 5(1):18. PubMed ID: 15985170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register.
    Holmström G; Hellström A; Gränse L; Saric M; Sunnqvist B; Wallin A; Tornqvist K; Larsson E
    Br J Ophthalmol; 2020 Jul; 104(7):943-949. PubMed ID: 31676594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinopathy of prematurity and serum level of insulin-like growth factor-1.
    Banjac L; Bokan V
    Acta Clin Croat; 2012 Jun; 51(2):209-13. PubMed ID: 23115944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet mass index can be a reliable marker in predicting the prognosis of retinopathy of prematurity in very preterm infants.
    Korkmaz L; Baştuğ O; Özdemir A; Korkut S; Karaca Ç; Akın MA; Öztürk MA
    Pediatr Neonatol; 2018 Oct; 59(5):455-463. PubMed ID: 29223489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.